FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

ImprimisRx CA, Inc., dba ImprimisRx Latanoprost PF Solution Recall

Latanoprost PF Solution, 0

ImprimisRx CA, Inc., dba ImprimisRx · Irvine, CA

Risk level
Class II
Reported by FDA
Sep 13, 2017
Recall ID
D-1131-2017
Check your lot numberHow we source this data

Summary

ImprimisRx CA, Inc., dba ImprimisRx recalled Latanoprost PF Solution starting Jun 23, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1131-2017 on Sep 13, 2017. Reason: Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier. Status: Terminated.

Why it was recalled

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Product description

Latanoprost PF Solution, 0.005%, Ophthalmic Drops in Sterile 5ml Bottles, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA

Lot numbers, UPCs & expiration codes

0404017@32B, 10/01/2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1131-2017
Classification
Class II
Status
Terminated
Recall initiated
Jun 23, 2017
FDA report date
Sep 13, 2017
Quantity
19 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
ImprimisRx CA, Inc., dba ImprimisRx

Original FDA data

Every field from FDA enforcement report D-1131-2017, exactly as published.

Show all FDA fields
City
Irvine
State
CA
Status
Terminated
Country
United States
Event ID
77647
Address
9257 Research Dr
Code information
0404017@32B, 10/01/2017
Postal code
92618-4286
Report date
Sep 13, 2017
Product type
Drugs
Recall number
D-1131-2017
Classification
Class II
Recalling firm
ImprimisRx CA, Inc., dba ImprimisRx
Product quantity
19 bottles
Termination date
Jan 14, 2019
Reason for recall
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Voluntary / mandated
Voluntary: Firm initiated
Product description
Latanoprost PF Solution, 0.005%, Ophthalmic Drops in Sterile 5ml Bottles, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA
Distribution pattern
Nationwide
Recall initiation date
Jun 23, 2017
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Sep 7, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1131-2017, published Sep 13, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls